Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.27.1 (RNase)
 16,360 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Suramin treatment (250 mg/kg bw) 24 and 48 h after administration is followed by the decreased rate of intralysosomal digestion of 14C-bovine albumin. Inhibition of proteolysis and lysosomal overloading with suramin cause the solubilization of acid hydrolases--beta-galactosidase, acid RNase, cathepsin D. There was a significant inhibition of acid phosphatase activity in the rat liver homogenate, suggesting that suramin might be used as a tool to study some features of lysosomal storage disease. Potential mechanisms of the decreased catabolic function of liver ribosomes during administration of lysosomal trophic drugs are discussed.
 ...
PMID:[Decrease in the rats of intraliposomal proteolysis and labilization of rat liver lysosomes following suramin administration]. 678 52